Meriva® highly bioavailable turmeric-phytosome
- Helps relieve joint inflammation and associated symptoms such as joint pain when used in conjunction with conventional treatment
- Provides antioxidants for the maintenance of good health
- Clinically studied for enhanced absorption
- Made with vegan ingredients
CurcumaSorb provides the patented Meriva® curcumin-phosphatidylcholine complex for enhanced absorption and bioavailability. The proprietary phytosome technology combines curcumin and phosphatidylcholine in a 1:2 ratio, promoting resistance to degradation in the digestive tract and efficient absorption across membranes. This produces significantly higher peak plasma concentrations and larger area under concentration-time curves (AUC). In a single-dose pharmacokinetic animal study, plasma curcumin levels were 20 times greater with Meriva® than standard curcumin. A preliminary human pharmacokinetic study demonstrated that elevations in plasma curcumin from 450 mg Meriva® were similar to values obtained from 4,000 mg of a standard curcumin extract. The efficacy of a low dose was demonstrated in a three-month clinical trial, in which 200 mg curcuminoids from Meriva® per day helped relieve joint inflammation and provided significant benefit in joint comfort, mobility and quality of life when used in conjunction with conventional treatment.
Pure Encapsulations products are free from wheat and gluten; egg; peanuts; coatings and shellacs; GMOs; magnesium stearate; trans fats and hydrogenated oils; artificial colours, flavours and sweeteners; unnecessary binders, fillers and preservatives. Any product containing ingredients derived from allergens, such as soy, dairy or shellfish, is clearly labeled. All two-piece capsules are hypoallergenic and vegetarian.